We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBUY icon
6251
Amplify Online Retail ETF
IBUY
$126M
-187
Closed -$7K
ICCC icon
6252
ImmuCell
ICCC
$99.2M
-153
Closed -$1K
ICCM icon
6253
IceCure Medical
ICCM
$11.2M
0
ICVT icon
6254
iShares Convertible Bond ETF
ICVT
$7.42B
-100
Closed -$7K
IDLV icon
6255
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
$0 ﹤0.01%
+12
New +$330
IEUR icon
6256
iShares Core MSCI Europe ETF
IEUR
$9.14B
-2,992
Closed -$135K
IGOV icon
6257
iShares International Treasury Bond ETF
IGOV
$1.53B
$0 ﹤0.01%
+11
New +$438
IHI icon
6258
iShares US Medical Devices ETF
IHI
$3.44B
$0 ﹤0.01%
4
-41,142
-100% -$2.13M
IIM icon
6259
Invesco Value Municipal Income Trust
IIM
$595M
$0 ﹤0.01%
+4
New +$53
IMMX icon
6260
Immix Biopharma
IMMX
$721M
$0 ﹤0.01%
+250
New +$546
IMNM icon
6261
Immunome
IMNM
$2.91B
-2,489
Closed -$8K
IMTM icon
6262
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
$0 ﹤0.01%
+5
New +$148
INDL icon
6263
Direxion Daily MSCI India Bull 2X ETF
INDL
$57.7M
$0 ﹤0.01%
+6
New +$291
INDY icon
6264
iShares S&P India Nifty 50 Index Fund
INDY
$565M
$0 ﹤0.01%
5
-244
-98% -$10.6K
INKT icon
6265
MiNK Therapeutics
INKT
$54.6M
-110
Closed -$2K
INTR icon
6266
Inter&Co
INTR
$2.36B
-2,233
Closed -$5K
INVZW
6267
DELISTED
Innoviz Technologies Warrant
INVZW
$0 ﹤0.01%
26
IOBT
6268
DELISTED
IO Biotech
IOBT
-524
Closed -$2K
IOO icon
6269
iShares Global 100 ETF
IOO
$9.47B
-236
Closed -$15K
IPAC icon
6270
iShares Core MSCI Pacific ETF
IPAC
$2.74B
$0 ﹤0.01%
+2
New +$105
IPHA
6271
Innate Pharma
IPHA
$208M
-2,600
Closed -$7K
IRIX icon
6272
IRIDEX
IRIX
$14.7M
$0 ﹤0.01%
36
-8,176
-100% -$22.3K
ISPOW
6273
DELISTED
Inspirato Inc Warrant
ISPOW
$0 ﹤0.01%
22
ISTR icon
6274
Investar Holding Corp
ISTR
$411M
-112
Closed -$2K
IUSV icon
6275
iShares Core S&P US Value ETF
IUSV
$27.8B
$0 ﹤0.01%
+7
New +$483

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.